Compare Appian Corp (APPN) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Appian Corp vs Health Care Select Sector SPDR Fund — how do they compare? Appian Corp trades at $26.4 (market cap $1.86B), while Health Care Select Sector SPDR Fund trades at $161.11. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Appian Corp nearer its low. Which is the better fit depends on your goals.
| APPN | XLV | |
|---|---|---|
Market Cap | $1.86B | — |
Sector | Technology | — |
52-Week High | $45.64 | $164.48 |
52-Week Low | $18.72 | $129.01 |
Enterprise Value | $1.95B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Appian (APPN) trades at $25.36, up 0.48% on the day, with a bullish technical signal from moving averages and a consensus price target of $26.20. The company reported positive net income in 2025 after years of losses, with revenue growing to $726.94M and operating cash flow improving to $62.87M. Recent news highlights focus on AI strategy and enterprise adoption, though the CEO's share sale and negative shareholder equity present mixed signals.
The outlook is cautiously optimistic with revenue growth and cash flow recovery, but risks include high debt levels, negative equity, and intense competition. Analyst sentiment is mixed with a majority Hold rating. The stock offers potential from AI-driven growth but requires monitoring of profitability sustainability and balance sheet health.
XLV trades at $160.84, down 0.82% with a bullish technical signal from moving averages. The healthcare ETF shows defensive characteristics amid market volatility, with recent news highlighting its stability versus biotech alternatives. Technical indicators show mixed signals with RSI at neutral levels while ADX indicates strong trend momentum.
Healthcare sector rotation provides support as investors seek defensive exposure. Key risks include patent cliff concerns and regulatory pressures, while innovation in medical technology offers growth potential. The ETF's diversification across 59 healthcare names provides stability compared to concentrated biotech funds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
